[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:ar-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"AR Gene",4,3,[8,16,23,29],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05095207","Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:19:00.742020Z","2026-05-05T02:43:28.419912Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT04573231","Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer",[20],"Phase 2","2026-08-26T02:16:46.147215Z","2026-05-05T02:43:27.739572Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT04708431","Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen Insensitivity",[],"2026-08-26T02:16:54.876240Z","2026-07-05T05:32:16.794546Z",{"nct_id":30,"title":31,"phases":32,"status":33,"updated_at":34,"content_modified":35},"NCT03942653","Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma",[20],"ACTIVE_NOT_RECRUITING","2026-08-03T03:37:48.267540Z","2026-05-05T02:43:27.307762Z"]